6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Originaltext

Diese Übersetzung bewerten

Mit deinem Feedback können wir Google Übersetzer weiter verbessern

Latest Press Releases

Time	Headline
28m ago	Sunrun Prices $584 million Securitization of Residential Solar and Storage Assets
28m ago	Madison Air Schedules First Quarter 2026 Earnings Conference Call and Webcast
52m ago	Ultra Clean Announces Retirement of the Chief Financial Officer Sheri Savage
52m ago	GridAI Technologies Corp. Announces Receipt of NASDAQ Notice Regarding Late Form 10-K Filing
52m ago	Rush Enterprises, Inc. Reports First Quarter 2026 Results, Announces $0.19 Per Share Dividend

About

Formosa Pharmaceuticals, Inc. (TW:6838) — investor relations, events, news, and company updates on 6ix.

Latest News

Formosa Pharmaceuticals Announces Licensing Agreement with Samil Pharmaceuticals, Co., Ltd, for Commercialization of Clobetasol Propionate Ophthalmic Suspension for the Treatment of Inflammation and Pain Following Ocular Surgery

Formosa Pharmaceuticals Announces Licensing Agreement with Rxilient, for Commercialization of Clobetasol Propionate Ophthalmic Suspension for the Treatment of Inflammation and Pain Following Ocular Surgery

Financials

Revenue

NT$9.49 M

Market Cap

NT$4.22 B

EPS

-0.55

Community Chat

Ask AI